toyocamycin has been researched along with nsc 65346 in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (33.33) | 18.7374 |
1990's | 6 (20.00) | 18.2507 |
2000's | 8 (26.67) | 29.6817 |
2010's | 6 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernier-Rodriguez, M; Drach, JC; Kern, ER; Krawczyk, SH; Nassiri, MR; Townsend, LB; Wotring, LL | 1 |
Daunert, S; Drach, JC; Gupta, PK; Nassiri, MR; Townsend, LB; Wotring, LL | 1 |
Balzarini, J; De Clercq, E; Hansske, F; Madej, D; Robins, MJ | 1 |
Balzarini, J; Bergstrom, DE; Brattesani, AJ; De Clercq, E; Ogawa, MK; Reddy, PA; Schweickert, MJ | 1 |
Drach, JC; Renau, TE; Townsend, LB; Wotring, LL | 1 |
Browne, CE; DaRe, JM; Erion, MD; Kopcho, JJ; Schanzer, JM; Ugarkar, BG; Wiesner, JB | 1 |
Debnath, B; Jha, T; Srikanth, K | 1 |
González, MP; Moldes del Carmen Terán, M | 1 |
Caballero, J; Fernández, M; González-Nilo, FD | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Feng, Y; Hooper, JN; Mellick, G; Murtaza, M; Quinn, RJ; Wang, D; Wood, S | 1 |
Barbeau, O; Burke, R; Cheeseman, MD; Collins, I; Dobson, S; Jeganathan, F; Jones, AM; Jones, K; Kadi, N; Rowlands, M; van Montfort, RL; Westwood, IM; Workman, P | 1 |
Bayle, ED; Fish, PV; Li, F; Schapira, M; Spurr, SS; Tempel, W; Vedadi, M; Yu, W | 1 |
Coleman, LA; Drach, JC; Saxena, NK; Townsend, LB | 1 |
Hargrave, PA; Kahn, N; Palczewski, K | 1 |
Coleman, LA; Drach, JC; Gupta, PK; Nassiri, MR; Townsend, LB; Wotring, LL | 1 |
Cohen, MB; Glazer, RI | 2 |
Bojarska, E; Czochralska, B; Pawlicki, K | 1 |
Cheng, HW; Rice, A; Verham, R; Wang, AL; Wang, CC | 1 |
Gupta, RS; Mehta, KD | 1 |
Glazer, RI; Saffer, JD | 1 |
Drach, JC; Kern, ER; Krawczyk, SH; Kucera, LS; Nassiri, MR; Ptak, RG; Townsend, LB; Wotring, LL | 1 |
Breitenbach, JM; Drach, JC; Kennedy, C; Ptak, RG; Renau, TE; Townsend, LB | 1 |
Kato, A; Maeba, I; Nishimura, N | 1 |
An, H; Ding, Y; Girardet, JL; Hong, Z | 1 |
Bandarian, V; McCarty, RM | 1 |
Kang, J; Lee, CH; Lee, DK | 1 |
Bandarian, V; Nelp, MT; Song, Y; Wysocki, VH | 1 |
Bai, J; Ding, H; Dong, X; Hu, C; Tang, J; Xiao, Q | 1 |
30 other study(ies) available for toyocamycin and nsc 65346
Article | Year |
---|---|
Arabinofuranosylpyrrolo[2,3-d]pyrimidines as potential agents for human cytomegalovirus infections.
Topics: Animals; Antiviral Agents; Arabinonucleosides; Cell Division; Chemical Phenomena; Chemistry; Cytomegalovirus; Cytomegalovirus Infections; Humans; Leukemia L1210; Mice; Molecular Structure; Pyrimidine Nucleosides; Simplexvirus; Structure-Activity Relationship; Toyocamycin; Tumor Cells, Cultured | 1990 |
Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antiviral Agents; Cell Division; Humans; Mice; Pyrimidine Nucleosides; Structure-Activity Relationship; Toyocamycin; Tubercidin | 1989 |
Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin.
Topics: Animals; Antibiotics, Antineoplastic; Antiviral Agents; Formycins; Leukemia L1210; Mice; Microbial Sensitivity Tests; Pyrimidine Nucleosides; Ribonucleosides; Structure-Activity Relationship; Toyocamycin; Tubercidin | 1987 |
Antiviral activity of C-5 substituted tubercidin analogues.
Topics: Animals; Antibiotics, Antineoplastic; Antiviral Agents; Chlorocebus aethiops; DNA Viruses; HeLa Cells; Humans; Mice; Pyrimidine Nucleosides; Rabbits; Ribonucleosides; RNA Viruses; Toyocamycin; Tubercidin | 1984 |
Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Topics: Antiviral Agents; Cell Survival; Cells, Cultured; Cytomegalovirus; Fibroblasts; Herpesvirus 1, Human; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Microbial Sensitivity Tests; Molecular Structure; Pyrimidine Nucleosides; Pyrimidines; Skin; Structure-Activity Relationship; Thionucleosides; Toyocamycin; Viral Plaque Assay | 1996 |
Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues.
Topics: Adenosine Kinase; Animals; Anticonvulsants; Electroshock; Enzyme Inhibitors; Humans; Male; Rats; Recombinant Proteins; Seizures; Structure-Activity Relationship; Tubercidin | 2000 |
QSAR study on adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues using the hansch approach.
Topics: Adenosine Kinase; Biodegradation, Environmental; Hydrophobic and Hydrophilic Interactions; Ligands; Pyrimidines; Pyrroles; Quantitative Structure-Activity Relationship | 2002 |
A TOPS-MODE approach to predict adenosine kinase inhibition.
Topics: Adenosine Kinase; Enzyme Inhibitors; Models, Molecular; Predictive Value of Tests; Quantitative Structure-Activity Relationship | 2004 |
A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues.
Topics: Adenosine Kinase; Computer Simulation; Databases, Factual; Enzyme Inhibitors; Models, Chemical; Models, Molecular; Molecular Structure; Nucleosides; Pyrimidines; Pyrroles; Quantitative Structure-Activity Relationship; Reproducibility of Results; Stereoisomerism | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
A Grand Challenge: Unbiased Phenotypic Function of Metabolites from Jaspis splendens against Parkinson's Disease.
Topics: Animals; Depsipeptides; Drug Screening Assays, Antitumor; Humans; Indole Alkaloids; Molecular Structure; Parkinson Disease; Porifera | 2016 |
Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70.
Topics: Adenosine; Crystallography, X-Ray; Dose-Response Relationship, Drug; HSP70 Heat-Shock Proteins; Humans; Models, Molecular; Molecular Conformation; Structure-Activity Relationship | 2016 |
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
Topics: Crystallography; Enzyme Inhibitors; Halogens; Histone-Lysine N-Methyltransferase; Methyltransferases; Nitriles; Small Molecule Libraries; Structure-Activity Relationship | 2016 |
Synthesis and antiviral activity of some 7-[(2-hydroxyethoxy)methyl]pyrazolo[3,4-d]pyrimidine analogues of sangivamycin and toyocamycin.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; Dose-Response Relationship, Drug; Humans; Indicators and Reagents; KB Cells; Molecular Structure; Pyrimidine Nucleosides; Simplexvirus; Structure-Activity Relationship; Toyocamycin; Viral Plaque Assay | 1990 |
Nucleoside inhibitors of rhodopsin kinase.
Topics: Adenosine; Animals; Binding Sites; Cattle; Eye Proteins; G-Protein-Coupled Receptor Kinase 1; Molecular Conformation; Nucleosides; Protein Kinase Inhibitors; Protein Kinases; Pyrimidine Nucleosides; Toyocamycin | 1990 |
Synthesis, cytotoxicity, and antiviral activity of certain 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine nucleosides related to toyocamycin and sangivamycin.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antiviral Agents; Cell Survival; Cells, Cultured; Chemical Phenomena; Chemistry; Haplorhini; Humans; Mice; Pyrimidine Nucleosides; Pyrroles; Toyocamycin | 1989 |
Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
Topics: Azacitidine; Azaguanine; Cell Survival; Cells, Cultured; Colonic Neoplasms; Fluorouracil; Humans; Protein Biosynthesis; Pyrimidine Nucleosides; RNA, Ribosomal; Toyocamycin; Tubercidin | 1985 |
Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.
Topics: Antibiotics, Antineoplastic; Cell Survival; Colonic Neoplasms; Humans; In Vitro Techniques; Leucine; Methylation; Protein Biosynthesis; Pyrimidine Nucleosides; Ribonucleosides; RNA; RNA, Ribosomal; Time Factors; Toyocamycin; Uridine | 1985 |
Electrochemical study of the reduction of toyocamycin and sangivamycin in aqueous media.
Topics: Aminoglycosides; Anti-Bacterial Agents; Electrolysis; Horseradish Peroxidase; Oxidation-Reduction; Photochemistry; Polarography; Pyrimidine Nucleosides; Toyocamycin | 1987 |
Differential effects of inhibitors of purine metabolism on two trichomonad species.
Topics: Alanine; Animals; Chromatography, High Pressure Liquid; Formycins; Glycine; Mycophenolic Acid; Purine Nucleotides; Purines; Pyrimidine Nucleosides; Species Specificity; Toyocamycin; Trichomonas vaginalis; Tritrichomonas; Tubercidin; Vidarabine | 1984 |
Genetic and biochemical studies on mutants of CHO cells resistant to 7-deazapurine nucleosides: differences in the mechanisms of action of toyocamycin and tubercidin.
Topics: Animals; Cell Line; Cricetinae; Cricetulus; Drug Resistance; Female; Macromolecular Substances; Mutation; Ovary; Pyrimidine Nucleosides; Ribonucleosides; Toyocamycin; Tubercidin | 1984 |
Inhibition of histone H1 phosphorylation by sangivamycin and other pyrrolopyrimidine analogues.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Nucleus; Histones; In Vitro Techniques; Mice; Phosphorylation; Protein Kinase Inhibitors; Pyrimidine Nucleosides; RNA, Neoplasm; Toyocamycin | 1981 |
Synthesis and antiproliferative and antiviral activity of 2'-deoxy-2'-fluoroarabinofuranosyl analogs of the nucleoside antibiotics toyocamycin and sangivamycin.
Topics: Antibiotics, Antineoplastic; Antiviral Agents; Arabinonucleosides; Cytomegalovirus; Herpesvirus 1, Human; HIV; Humans; KB Cells; Pyrimidine Nucleosides; Toyocamycin | 1995 |
Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines.
Topics: Antiviral Agents; Cytomegalovirus; Herpesvirus 1, Human; Humans; Pyrimidine Nucleosides; Pyrimidines; Structure-Activity Relationship; Thionucleosides; Toyocamycin | 1996 |
Synthesis of pyrrolo[2,1-f][1,2,4]triazine C-nucleosides. Isosteres of sangivamycin, tubercidin, and toyocamycin.
Topics: Antibiotics, Antineoplastic; Indicators and Reagents; Pyrimidine Nucleosides; Ribonucleosides; Spectrometry, Mass, Fast Atom Bombardment; Stereoisomerism; Toyocamycin; Triazines; Tubercidin | 2001 |
Synthesis of 2'-beta-C-methyl toyocamycin and sangivamycin analogues as potential HCV inhibitors.
Topics: Adenosine; Antiviral Agents; Hepacivirus; Pyrimidine Nucleosides; Replicon; Structure-Activity Relationship; Toyocamycin | 2005 |
Deciphering deazapurine biosynthesis: pathway for pyrrolopyrimidine nucleosides toyocamycin and sangivamycin.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Gene Expression Regulation, Bacterial; GTP Cyclohydrolase; Hydro-Lyases; Molecular Sequence Data; Multigene Family; Purines; Pyrimidine Nucleosides; Pyrimidines; Pyrroles; Streptomyces; Toyocamycin | 2008 |
Cell cycle arrest and cytochrome c-mediated apoptotic induction in human lung cancer A549 cells by MCS-C2, an analogue of sangivamycin.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cytochromes c; Humans; Lung Neoplasms; Pyrimidine Nucleosides; Toyocamycin | 2010 |
A Protein-derived Oxygen Is the Source of the Amide Oxygen of Nitrile Hydratases.
Topics: Actinomycetales; Catalytic Domain; Crystallography, X-Ray; Hydro-Lyases; Models, Molecular; Oxygen; Pyrimidine Nucleosides; Toyocamycin | 2016 |
An Expeditious Total Synthesis of 5'-Deoxy-toyocamycin and 5'-Deoxysangivamycin.
Topics: Glycosylation; Models, Molecular; Molecular Structure; Pyrimidine Nucleosides; Toyocamycin | 2019 |